Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)

Local Institution, Brussels

Local Institution, B-leuven

Local Institution, Parkville

Local Institution, Woodville

Local Institution, Ghent

Hospital Duran I Reynals, Hospitalet Llobregat- Barcelona

Weill Cornell Medical College, New York

Local Institution, Milan

Local Institution, Bergamo

Duke University Medical Center, Durham

Local Institution, Madrid

Hospital Universitario La Paz, Madrid

Winship Cancer Institute., Atlanta

Local Institution, Montpellier

Local Institution, Rennes

Local Institution, Salamanca

Vanderbilt University Medical Center, Nashville

Local Institution, Bologna

Universitaetsklinikum Essen, Essen

Mayo Clinic, Rochester

Universitaetsklinikum d. Saarlandes, Homburg

Universitaetsklinikum Des Saarlandes, Homburg

Local Institution, Pierre-Bénite

MD Anderson Cancer Center, Houston

Local Institution, Napoli

Huntsman Cancer Institute, Salt Lake City

Mayo Clinic Arizona, Phoenix

Universitaetsklinikum Ulm, Ulm

Division Of Hematology & Oncology Ctr. For Health Sciences, Los Angeles

Local Institution, Regensburg

Local Institution, Créteil

Local Institution, Singapore

Local Institution, Singapore

Beth Israel Deaconess Medical Center (BIDMC), Boston

Dana Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

Jewish General Hospital, Montreal

CISSS du Bas-Saint-Laurent Hopital Regional de Rimouski, Rimouski

Local Institution, Roma

Local Institution, Oslo

Local Institution, Gothenberg

Local Institution, Gothenburg

Local Institution, Southampton

Local Institution, Withington

Local Institution, Sutton